1h Free Analyst Time
The women's health therapeutics market is poised to grow by $30.35 bn during 2022-2026, accelerating at a CAGR of 5.74% during the forecast period. The report on the women's health therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by strategic alliances.
The women's health therapeutics market analysis includes the type segment and geographic landscape.
The women's health therapeutics market is segmented as below:
By Type
- Fertility
- Oncology
- Menopause
- Infection
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on women's health therapeutics market covers the following areas:
- Women's health therapeutics market sizing
- Women's health therapeutics market forecast
- Women's health therapeutics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Type
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global women's health therapeutics market: Abbott Laboratories, AbbVie Inc., Amgen Inc., Bayer AG, Eli Lilly and Co., F. Hoffmann La Roche Ltd., GLS Pharma Pvt. Ltd., ICON plc, Merck KGaA, Novartis AG, Novo Nordisk AS, ObsEva SA, Pfizer Inc., Radius Health Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., TSUMURA and Co., Vivesto AB, and Mithra Pharmaceuticals SA.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is rising awareness of gynecological diseases.`
According to the report, one of the major drivers for this market is the strategic alliances.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- AbbVie Inc.
- Amgen Inc.
- Bayer AG
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- GLS Pharma Pvt. Ltd.
- ICON plc
- Merck KGaA
- Novartis AG
- Novo Nordisk AS
- ObsEva SA
- Pfizer Inc.
- Radius Health Inc.
- Sanofi SA
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
- TSUMURA and Co.
- Vivesto AB
- Mithra Pharmaceuticals SA
